6171 - 6180 of 9030 Results
Title
Year
-
OPENTitle: Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/241754Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/241754.pdfCitation Count: 37
-
OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 35
- Attitudes toward use and timing of deep brain stimulation: a patient’s with DBS perspective2021RESTRICTEDTitle: Attitudes toward use and timing of deep brain stimulation: a patient’s with DBS perspectiveJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 203Issue #:Start Page: 106553End Page: 106553Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106553Citation Count: 8
-
OPENTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Best OA location URL: https://doaj.org/article/63e10c65eb3f433c933e3bf217f2f015Citation Count: 150
-
OPENTitle: Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 99End Page: 99Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00363-2Best OA location URL: https://www.nature.com/articles/s41531-022-00363-2.pdfCitation Count: 30
-
OPENTitle: Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 5Start Page: 893End Page: 906Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25897Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25897Citation Count: 110
-
OPENTitle: Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological WorkflowJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 93Issue #: 32Start Page: 11108End Page: 11115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acs.analchem.1c01128Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.1c01128Citation Count: 8
- Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature2025RESTRICTEDTitle: Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signatureJournal Name: NeurosciencePublisher: Elsevier BVVol: 593Issue #:Start Page: 41End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2025.12.011Citation Count: 1
-
OPENTitle: A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disordersJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1870Issue #: 5Start Page: 167131End Page: 167131Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbadis.2024.167131Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0925443924001200-ga1_lrg.jpgCitation Count: 3
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 16
